Newcastle Tests Gene Therapy for Leading Kidney Disease in Kids

For children with nephronophthisis, the clock starts ticking early. This inherited kidney disease has no treatment to slow it down, and most patients need dialysis or transplants before they leave their teenage years.

Now, Professor John Sayer and his team at Newcastle University are testing whether gene therapy could change that story. With £110,000 in funding, they're exploring a treatment that could rescue damaged kidney cells before they fail.

The disease happens when genetic changes affect tiny structures called cilia on kidney cells. These cilia act like cellular antennae, helping cells respond to their environment. When they malfunction, scar tissue and cysts replace healthy kidney tissue, leading to kidney failure.

What makes this research especially clever is how they're doing it. When urine passes through the kidneys, cells from the kidney lining naturally shed into it. That means researchers can study actual kidney cells from patients without invasive procedures.

The gene therapy being tested works by telling the body to ignore certain genetic errors and read the full instructions in the gene. If successful, this could help produce complete, functional proteins that build healthy cilia.

Professor Sayer treats many of these young patients himself. "Most of the patients I see who have nephronophthisis reach kidney failure in their childhood or teenage years," he explains. He's been working with families for years to find ways to diagnose the condition sooner and identify treatments that could prevent kidney failure.

The research is co-funded by The Cook Fund, created by parents Nick and Helen Cook, whose three sons all have kidney disease. Their partnership with Kidney Research UK is funding new approaches to childhood kidney conditions that have been overlooked for too long.

Why This Inspires

This research represents hope for families who've had none. Gene therapy was once science fiction, but now it's being tested in urine samples collected from real patients with real needs. The work combines cutting-edge science with deeply personal motivation, from a doctor who sees these kids in his clinic and parents who understand the urgency firsthand.

If the lab results show promise, this could open the door to clinical trials and eventually a treatment that lets children with nephronophthisis keep their kidneys and their childhood dreams intact.